Control of Myoblast Proliferation with a Synthetic Ligand
Open Access
- 1 November 2001
- journal article
- Published by Elsevier
- Vol. 276 (44) , 41191-41196
- https://doi.org/10.1074/jbc.m103191200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusionJournal of Cellular Physiology, 2000
- A Novel Means of Drug Delivery: Myoblast-Mediated Gene Therapy and Regulatable Retroviral VectorsAnnual Review of Pharmacology and Toxicology, 2000
- Signal transduction by fibroblast growth factor receptorsFrontiers in Bioscience-Landmark, 1999
- Skeletal myoblast transplantation for repair of myocardial necrosis.Journal of Clinical Investigation, 1996
- Identification of Six Novel Autophosphorylation Sites on Fibroblast Growth Factor Receptor 1 and Elucidation of Their Importance in Receptor Activation and Signal TransductionMolecular and Cellular Biology, 1996
- Myoblast Transfer in the Treatment of Duchenne's Muscular DystrophyNew England Journal of Medicine, 1995
- FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFR1Developmental Biology, 1992
- Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse.The Journal of cell biology, 1990
- Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.The Journal of cell biology, 1987
- Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblastsBiochemistry, 1986